On March 19, a delegation from BOC International Investment, Bank of China, BOC Securities, and Yunnan Baiyao Group visited the company for a collaborative exchange. Attendees included Shen Fanshun, Party Branch Secretary and Chairman, Liu Yan, Deputy General Manager and Committee Member, along with heads of the Strategic Development Department, Financial Management Department, and Party-Mass Integration Department. The delegation toured the company's exhibition hall, where they learned about its core operations, product portfolio, and R&D capabilities. During the symposium, Shen Fanshun detailed the company's growth trajectory, equity structure, traditional Chinese medicine (TCM) industry framework, breakthroughs in innovative herbal preparations and wellness products, as well as future development plans. Discussions focused on TCM industry innovation, equity restructuring, IPO preparations, resource synergies, and potential collaborations. Shen emphasized the company's commitment to advancing TCM wellness initiatives and modernizing the industry. He expressed openness to attracting strategic investors and partners, particularly looking forward to deepening cooperation with BOC Group and Yunnan Baiyao Group in upgrading the TCM supply chain, building resource platforms, expanding markets, and optimizing capital operations.